Ken Griffin
APYX icon

Ken Griffin’s Apyx Medical APYX Stock Holding History

Ken Griffin’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,100
Closed -$31.6K – 12425
2025
Q1 		$31.6K Buy
+23,100
New +$31.8K ﹤0.01% 12767
2024
Q4 		– Sell
-17,800
Closed -$22.1K – 14452
2024
Q3 		$22.1K Sell
17,800
-5,200
-23% -$6.57K ﹤0.01% 12708
2024
Q2 		$30.8K Buy
23,000
+7,000
+44% +$10.3K ﹤0.01% 12239
2024
Q1 		$21.8K Buy
+16,000
New +$34K ﹤0.01% 12954
2023
Q4 		– Sell
-2,600
Closed -$8.32K – 14225
2023
Q3 		$8.32K Sell
2,600
-18,800
-88% -$87.6K ﹤0.01% 13197
2023
Q2 		$108K Buy
21,400
+14,800
+224% +$75K ﹤0.01% 10823
2023
Q1 		$19K Buy
6,600
+3,400
+106% +$9.93K ﹤0.01% 13103
2022
Q4 		$7.49K Buy
+3,200
New +$9.77K ﹤0.01% 13819
2022
Q3 		– Sell
-12,700
Closed -$74K – 12544
2022
Q2 		$74K Buy
+12,700
New +$65.2K ﹤0.01% 11656

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Ken Griffin's APYX Position: Q1 2026 in Review

Ken Griffin opened a new position in Apyx Medical (APYX) in Q1 2026: 107,798 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #9825 among its holdings. This is a return to the name: Ken Griffin previously reported a position in APYX as recently as Q3 2025.

Ken Griffin first reported a position in APYX in Q1 2016 and has held it in 24 quarters since. The position peaked at $689K in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Ken Griffin held 107,798 shares of Apyx Medical worth $398K as of Q1 2026.
  • Apyx Medical was a new Ken Griffin position in Q1 2026.
  • Apyx Medical made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #9825 holding.
  • Ken Griffin first reported a position in Apyx Medical in Q1 2016 and has held it in 24 quarters since.
  • Ken Griffin's Apyx Medical position peaked at $689K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.